Nitto Avecia Pharma Services: API To Clinic Within 4 Months

June 24th, 2019 by aveciapharma

Nitto Avecia Pharma Services, Inc. has a focused vision. We envision each engagement with prospective or long-term clients as an opportunity to deliver innovative ideas that support their mission. Our corporate vision is "Creating Wonders," and we take that to heart with each service we provide, priding...

Read Full Story »

Posted in: Outsourced Pharma

Nitto Avecia Pharma Services Corporate Overview

January 30th, 2019 by aveciapharma

Click here to download Nitto Avecia Pharma Services Corporate Overview brochure....

Read Full Story »

Posted in: Outsourced Pharma

Avecia Announces Opening of Cambridge, MA Office

February 1st, 2018 by aveciapharma

CAMBRIDGE, MA – Nitto Denko Avecia, Inc. (Avecia), a leader in oligonucleotide API (active pharmaceutical ingredient) manufacturing, announced today the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible...

Read Full Story »

Posted in: Company News, Press Release

Nitto Avecia Pharma Services Appoints Raymond Kaczmarek as President

January 15th, 2018 by aveciapharma

NITTO AVECIA PHARMA SERVICES APPOINTS RAYMOND KACZMAREK AS PRESIDENT IRVINE, CA – Nitto Avecia Pharma Services, Inc. (Avecia Pharma), a leading CGMP contract development and manufacturing organization (CDMO), announced today that it has appointed Raymond Kaczmarek to the position of President....

Read Full Story »

Posted in: Company News, Press Release

Nitto Avecia Completes Multiple Successful Oligonucleotide Manufacturing Synthesis Runs at 1.6 Mol Scale

November 7th, 2017 by aveciapharma

MILFORD, MA – Nitto Avecia, Inc. (Avecia) announced today the successful completion of the first synthesis runs at the 1.6 Mol scale which is believed to be the largest synthesis scale ever executed for oligonucleotide API (active pharmaceutical ingredients) at its new oligonucleotide manufacturing facility...

Read Full Story »

Posted in: Press Release

Nitto Denko Avecia Announces Opening of Manufacturing Expansion

July 26th, 2017 by aveciapharma

Nitto Denko Avecia Inc. (Avecia) has announced the opening of its new oligonucleotide API (active pharmaceutical ingredients) manufacturing facility in Milford, MA. The opening will commence with a ribbon cutting ceremony in August 2017 onsite at the Milford, MA facility. The ceremony will open with...

Read Full Story »

Posted in: Company News

Our Recent Exhibits & Tours

May 17th, 2017 by aveciapharma

It's been a busy month so far at Nitto Avecia Pharma Services! We exhibited at two major industry events, both held in San Diego - the 2017 AAPS National Biotechnology Conference and the 2017 TIDES Oligonucleotide and Peptide Therapeutics Annual Meeting. These events gave us the opportunity to meet with...

Read Full Story »

Posted in: Company News

AAPS National Biotechnology Conference

April 25th, 2017 by aveciapharma

We will be attending the AAPS National Biotechnology Conference in San Diego from May 1st to May 3rd. This year's main topics for the conference will be: Bioanalysis & Biomarkers, Biosimilars, Emerging Topics, Formulation Development, Drug Delivery & Manufacturing, and Novel Therapeutic Constructs &...

Read Full Story »

Posted in: Company News

Nitto Avecia Announces Multiple Oligonucleotide Expansions

November 14th, 2016 by aveciapharma

MILFORD, MA – Nitto Avecia Inc. (Avecia) today released its progress in expanding the company’s analytical development and oligonucleotide manufacturing capacities. The announcement signals the continuation of Avecia’s robust growth strategy to significantly increase its oligonucleotide...

Read Full Story »

Posted in: Press Release

Nitto Denko Avecia, Inc. Acquires the Businesses of Irvine Pharmaceutical Services & Avrio Biopharmaceuticals

October 11th, 2016 by aveciapharma

MILFORD, MA – Nitto Denko Avecia, Inc. (Avecia), today announced it has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio Biopharmaceuticals (Avrio), both located in Irvine, CA. Irvine is a leading analytical development services...

Read Full Story »

Posted in: Company News, Press Release


Back to Top
Cal. Civ. Code § 1798.102 - Do Not Sell My Personal Information